CDIO
Cardio Diagnostics Holdings, Inc.Company with tickers: CDIO, CDIOW
CIK
1870144
CUSIP
14159C202
Shares Outstanding
2,959,469
13F Activity (30d)
11 filings
10 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $2,680 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,787,517 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $129,776 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-1,784,837 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-1,788,158 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.63 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.63 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |